KIDNEY TRANSPLANTATION
Clinical trials for KIDNEY TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANTATION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a common stomach pill speed up recovery for new kidney transplants?
Disease control Recruiting nowThis study is testing if a medicine called vonoprazan fumarate, taken for one week around the time of surgery, can help a newly transplanted kidney start working right away. It is for adults getting their first kidney transplant from a deceased donor. The goal is to reduce the ne…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Apr 04, 2026 00:05 UTC
-
Could older transplant patients ditch a pill? trial tests cutting meds
Disease control Recruiting nowThis study aims to see if it's safe and effective to slowly stop one common anti-rejection drug (Mycophenolate Mofetil) in kidney transplant recipients aged 55 and older. Researchers will use special blood tests to closely monitor patients for signs of organ rejection or infectio…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Light therapy tested to save failing kidney transplants
Disease control Recruiting nowThis study is testing a treatment called extracorporeal phototherapy (ECP) for people with chronic kidney transplant rejection. ECP involves taking a patient's blood cells, treating them with ultraviolet light, and returning them to the body to calm the immune system. Researchers…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: NA • Sponsor: University Hospital, Angers • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Pig kidney transplant trial offers hope for patients out of options
Disease control Recruiting nowThis study is testing the safety and effectiveness of transplanting a kidney from a genetically modified pig into people with end-stage kidney disease. It is for patients who are either not eligible for a standard human kidney transplant or are on the waiting list but are unlikel…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE1, PHASE2 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
One-Time cell infusion could free kidney patients from lifelong drug burden
Disease control Recruiting nowThis trial is testing whether a one-time infusion of specially grown immune cells can help prevent a patient's body from rejecting a new kidney. The goal is to see if this cell therapy allows patients to safely take fewer anti-rejection drugs long-term. Researchers will compare p…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE2 • Sponsor: Singulera Therapeutics Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Pig kidney breakthrough offers hope for patients out of options
Disease control Recruiting nowThis study is testing a kidney from a genetically modified pig as a transplant for people with end-stage kidney disease who are on dialysis. It's for patients who are not eligible for a human kidney transplant or are unlikely to get one in time. The main goals are to see if the t…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE1, PHASE2 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New drug trial aims to stop kidney transplant rejection
Disease control Recruiting nowThis study is testing whether an experimental drug called ALXN2030 can help control antibody-mediated rejection in adults who have received kidney transplants. About 45 participants will receive either one of two doses of ALXN2030 or a placebo for 52 weeks, along with their stand…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Online program aims to empower kidney transplant and cancer survivors
Symptom relief Recruiting nowThis study is testing a 6-week online group program to help people in Israel who have had a kidney transplant or are cancer survivors. The program teaches practical skills for managing symptoms like fatigue and pain, communicating with doctors, and improving daily life. Researche…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: NA • Sponsor: University of Haifa • Aim: Symptom relief
Last updated Apr 03, 2026 14:42 UTC